A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic
What is the efficacy of combination chemotherapy and ruxolitinib for the treatment
of B-cell acute lymphoblastic leukemia in children?
Basic Study Information
Purpose:Location: University of Rochester Medical Center
This is a nonrandomized study of ruxolitinib in combination with a standard multi-agent
chemotherapy regimen for the treatment of B-cell acute lymphoblastic leukemia. Part
1 of the
study will optimize the dose of study drug (ruxolitinib) in combination with the chemotherapy
regimen. Part 2 will evaluate the efficacy of combination chemotherapy and ruxolitinib
recommended dose determined in Part 1.
Lead Researcher (Principal Investigator)
Lead Researcher: Angela Girvin
Study Contact Information
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search